Furthermore, formononetin induced downregulation of microRNA-21 (miR-21), which functions as an oncogene in bladder cancer, which suggests that formononetin could be an effective agent that modulates oncogenic microRNA targeting PTEN (Wu et al., 2017). Here, PTEN is linked to urinary bladder carcinoma.